Navigation Links
Media Advisory - Oncolytics Biotech Inc. to Present at Rodman Renshaw 11th Annual Healthcare Conference
Date:9/8/2009

CALGARY, Sept. 8 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the Rodman Renshaw 11th Annual Healthcare Conference on Thursday, September 10, 2009 at 10:00 a.m. ET. The event will be held at the New York Palace Hotel from September 9 to 11, 2009.

A live audio webcast of the presentation will be available at: http://www.wsw.com/webcast/rrshq15/oncy or on the company's website at www.oncolyticsbiotech.com. It is recommended that listeners log on 15 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible following the presentation at www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

The presentation and webcast times are subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control and which
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Metabolism Publishes Novel TGR5-Mediated Mechanism for the Treatment of Diabetes and Obesity
2. DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice
3. BloodStor(TM) Stem Cell Biopreservation Media Platform Launched by BioLife Solutions
4. Bio-enabled, surface-mediated approach produces nanoparticle composites
5. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
6. Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit
7. BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products
8. Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy
9. Pfizer Global R&D Presents 2008 Top Intermediates CMO Award to Asymchem
10. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009
11. Rutgers University Cell and DNA Repository Adopts BioLife Solutions CryoStor(TM) as Standard Biopreservation Media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... WORTH, Texas , July 27, 2015 ... Media Market by Type (Home-brew Media, Pre-formulated Media), by Application ... America , Europe , ... Forecast to 2019", The global biopreservation media market was valued ... to around $571.5 million by 2019, at a CAGR of ...
(Date:7/27/2015)... WESTBROOK, Maine , July 27, 2015 ... that more than 8,000 clinics have submitted over 100,000 ... SDMA, testing in just the first 10 days since ... Chronic kidney disease (CKD) is a leading cause of ... from the submitted specimens are consistent with generally accepted ...
(Date:7/25/2015)... ... July 25, 2015 , ... Technology leader Anton ... checks and adjusts the surface temperature of the measuring prism. This is required ... data traceability and documentation are key requirements. It is likely that no refractometer ...
(Date:7/24/2015)... , July 24, 2015 ... equities: PDL BioPharma Inc. (NASDAQ: PDLI ), Arena ... STEM ), Northwest Biotherapeutics Inc. (NASDAQ: NWBO ... Free research report on PDL BioPharma can be accessed ... the NASDAQ Composite ended at 5,146.41, down 0.49%, the ...
Breaking Biology Technology:Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... ExL Pharma, Cision and the PRSA have,joined together ... relations executives the first Pharmaceutical Public Relations,Symposium in ... event will cover the key issues and challenges ... under ongoing political and media scrutiny,most notably as ...
... pharma industry is,not at a standstill: it has changed ... companies, profits, biological drugs are,now making their presence felt. ... impact, biologicals are providing the current focus for novel,discovery. ... rules,for their development are different and they are often ...
... (Nasdaq: JAZZ ) announced today that Nathaniel M.,Zilkha has ... 2007. The Company also announced that Adam H. Clammer has,resigned ... Mr. Zilkha is a Principal at Kohlberg Kravis Roberts & ... industry team. Prior to joining KKR,earlier this year, Mr. Zilkha ...
Cached Biology Technology:Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium 2Updated Drug Development Scrip Report Responds to the Pharma Industry's Major Changes 2
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... N.J. , June 25, 2015  TAKE Solutions ... a patent by the United States Patent and Trademark ... Standardization". This process leverages TAKE Solutions, Clinical Accelerators to ... over 50% (when compared to standardization without the accelerators), ... At the heart of ...
(Date:6/24/2015)... , June 24, 2015 Biometry authentication ... emerging biometric password solution one face in. ... one face in, entering the expanding ... and affordable multifactor-authentication biometric answer to the password ... provided in partnership with KeyLemon, one face in ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3TAKE Solutions Awarded Patent By USPTO 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... PA, February 20, 2013 A study published in the ... has determined that there is increasing evidence of a connection ... and dairy products, and that medical nutrition therapy (MNT) can ... 17 million Americans suffer from acne, mostly during their adolescent ...
... 2013) New findings by Columbia researchers suggest ... may be a second necessary factor for the development ... Alzheimer,s disease focus on the accumulation of amyloid plaque ... for Research on Alzheimer,s Disease and the Aging Brain, ...
... Identifying areas of malarial infection risk depends ... average monthly temperatures, according to a team of ... apply to environmentally temperature-dependent organisms other than the ... of several of the essential mosquito and parasite ...
Cached Biology News:Increasing evidence links high glycemic index foods and dairy products to acne 2New approach alters malaria maps 2
HSPBP1 Antibody...
... RACE (rapid amplification of cDNA ends) technique ... 5' and 3' cDNA ends. The GeneRacer ... Transcriptase (RT) for improved amplification of the ... mRNA. The RNase H portion of SuperScript ...
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Reactivity: Human...
Biology Products: